Publications by authors named "Bob Stork"

Claim this Profile
D
Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
Jos H M Lange, Hein K A C Coolen, Martina A W van der Neut, Alice J M Borst, Bob Stork

J Med Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity.
Jos H M Lange, Herman H van Stuivenberg, Willem Veerman, Henri C Wals, Bob Stork

Bioorg Med Chem Lett· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition.
Pieter Smid, Hein K A C Coolen, Hiskias G Keizer, Rolf van Hes, Jan-Peter de Moes, Bob Stork

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.
Jos H M Lange, Hein K A C Coolen, Herman H van Stuivenberg, Jessica A R Dijksman, Arnoud H J Herremans, Bob Stork

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis